Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.

Journal of neurology - 1 Jan 2015

Montagnese Federica, Barca E, Musumeci O, Mondello S, Migliorato A, Ciranni A, Rodolico C, De Filippi P, Danesino C, Toscano A

Abstract excerpt

Pompe disease is a rare metabolic disorder, due to mutations in the gene encoding acid alpha-glucosidase (GAA), of which infantile and late-onset forms may occur. Aim of the work was to analyze clinical and laboratory data of a cohort of late-onset Pompe disease (LOPD) patients, collected during the last 15 years and to point out unusual phenotypic/genotypic features as well as enzyme replacement therapy (ERT)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Glucosidases
Share to Analysis of Variance

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Enzyme Replacement Therapy

Share to Glycogen Storage Disease Type II

Share to Magnetic Resonance Imaging

Share to Muscle, Skeletal

Share to Respiration Disorders

Share to Severity of Illness Index

Source

Identifiers

PMID: 25673129
DOI: 10.1007/s00415-015-7664-0

Genes

GAA

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.PMID 25673129Read ↗

A Comprehensive Update on Late-Onset Pompe Disease.Semantic proximity Read ↗

A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations.Semantic proximity Read ↗

The new era of Pompe disease: Advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and managementSemantic proximity Read ↗

Prominent Respiratory Involvement Featured in High-Risk Screening for Late-Onset Pompe Disease in ChinaSemantic proximity Read ↗

Late-onset Pompe disease in France: molecular features and epidemiology from a nationwide study.Semantic proximity Read ↗

Phenotype variations in early onset Pompe disease: diagnosis and treatment results with Myozyme.Semantic proximity Read ↗

Pompe disease in Austria: clinical, genetic and epidemiological aspects.Semantic proximity Read ↗

The emerging phenotype of late-onset Pompe disease: A systematic literature review.Semantic proximity Read ↗

Pompe disease: clinical perspectivesSemantic proximity Read ↗

Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry.Semantic proximity Read ↗

Late Onset Pompe Disease with Novel Mutations and Atypical Phenotypes.Semantic proximity Read ↗

A Comprehensive Update on Pompe Disease: From Existing Therapies to Emerging Curative Strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.